Illinois Law Allows Medical Cannabis Patients to Purchase Cannabis Seeds. One Question About Their Availability Remains Unanswered.

I discussed this article on my podcast. You can view the episode here.

Illinois law has allowed qualifying medical cannabis patients to cultivate up to five cannabis plants since the Cannabis Regulation and Tax Act (CRTA) took effect in 2020.

The CRTA also authorizes registered qualifying patients to purchase cannabis seeds from licensed dispensaries for the purpose of home cultivation and provides that cannabis seeds must be obtained through Illinois’ regulated cannabis supply chain.

On its face, the law establishes a legal pathway for patients to lawfully obtain cannabis seeds for home cultivation.

More than six years later, however, one question I first raised years ago remains unanswered: does the technical limitation state officials identified in response to my 2022 inquiry still exist?

The question isn’t new

Questions surrounding cannabis seed sales are not new.

In February 2020, the Chicago Tribune reported that the Pritzker administration was working with state agencies, cultivators, and dispensaries to develop a process that would allow medical cannabis patients to purchase cannabis seeds.

“The administration is working with various state agencies, cultivators and dispensaries to develop a clear process that will allow the sale of seeds to medicinal users,” administration spokeswoman Charity Greene told the Tribune.

More than two years later, in May 2022, I contacted the Illinois Cannabis Regulation Oversight Office (CROO) to ask whether cannabis seeds were available through licensed dispensaries.

The office responded that, to its knowledge, no Illinois dispensaries were selling cannabis seeds.

More significantly, CROO provided me with this statement.

“To the CROO’s knowledge, there are no dispensaries selling seeds in Illinois. There would likely need to be changes to our seed-to-sale software (BioTrack) to allow for movement of dynamic products, like seeds. There is no requirement for medical licensees (cultivation centers and dispensaries) to supply seeds.”

That response suggested the issue was not the law itself. Instead, CROO indicated that Illinois’ seed-to-sale tracking software likely needed to be modified before regulated seed sales could occur.

Since then, Illinois has transitioned from BioTrack to the Metrc seed-to-sale tracking system. That transition gave rise to the central question underlying this article: if BioTrack was previously identified as the technical limitation, does that same limitation exist under Metrc, or has it been resolved?

Waiting for an answer

Earlier this year, I contacted the Illinois Department of Financial and Professional Regulation (IDFPR) seeking clarification on a straightforward question:

Does the BioTrack limitation identified by CROO in 2022 still exist?

IDFPR informed me that it was coordinating a joint response with the Illinois Department of Agriculture (IDOA). Over the following several weeks, I repeatedly followed up with both agencies but did not receive a substantive answer.

At no point did I ask whether Illinois law permits dispensaries to sell cannabis seeds. The law already answers that question.

Instead, I asked whether the technical limitation previously identified by state officials had been resolved.

At the time of publication, that question remains unanswered.

A new fact sheet highlights an existing provision

While my questions remained pending, Gov. JB Pritzker signed Senate Bill 3222 into law.

Following the bill’s enactment, IDFPR released a fact sheet summarizing various provisions of the legislation.

Among the items included was a statement that registered qualifying medical cannabis patients may purchase cannabis seeds from licensed dispensaries.

That language stood out to me because it predates Senate Bill 3222. The authority for registered qualifying medical cannabis patients to purchase cannabis seeds from licensed dispensaries has existed since the Cannabis Regulation and Tax Act took effect in 2020, and Senate Bill 3222 does not appear to make substantive changes to those statutory provisions.

I had already been seeking clarification from IDFPR and the Illinois Department of Agriculture regarding cannabis seed sales for several weeks before the bill was signed and before the fact sheet was released. As documented above, my inquiry concerned whether the technical limitation previously identified by the Cannabis Regulation Oversight Office still exists following Illinois’ transition from BioTrack to Metrc.

At the time of publication, the agencies have not yet provided a substantive response to that question.

Why this question matters now

For several years, many Illinois home growers have been able to obtain cannabis seeds through garden centers, hydroponic retailers, and online vendors marketing seeds through the hemp market.

Because those products have generally remained legal and readily available, the question of whether Illinois dispensaries sold cannabis seeds has not been particularly urgent for many medical cannabis patients.

That could soon change.

Beginning later this year, Senate Bill 3222 will subject cannabis products, including products currently marketed through the hemp market, to the Cannabis Control Act when sold outside Illinois’ regulated dispensary system. As a result, the Illinois cannabis industry could become an increasingly important source for patients seeking to lawfully obtain cannabis seeds for home cultivation.

This loss of access to the cannabis plant through traditional retail and online channels makes it all the more important to understand whether the technical limitation state officials identified years ago still exists.

Selling seeds may not make business sense

Even if the technical limitations identified in 2022 have been resolved, that does not necessarily mean cannabis seeds will become widely available through Illinois dispensaries.

As discussed earlier in this article, the Cannabis Regulation Oversight Office stated in 2022 that there is no requirement for cultivation centers to produce cannabis seeds or for dispensaries to sell them.

Industry sources familiar with commercial cannabis cultivation told me they would be surprised to see cultivators dedicate significant canopy space or other resources to breeding cannabis and producing seeds for retail sale. In addition to the time, expertise, and resources required to develop stable genetics, they noted that commercial cultivators generally generate revenue by producing flower and other finished cannabis products.

As one industry source said: selling seeds provides customers with the means to grow cannabis themselves rather than purchasing these finished products.

Several industry sources told me they believe those factors could continue to influence whether cannabis seeds become widely available through Illinois dispensaries, even if the technical limitations identified by state officials are ultimately resolved.

Awaiting clarification

Illinois law has seemingly authorized registered medical cannabis patients to purchase cannabis seeds from licensed dispensaries since 2020.

In 2022, state officials told me that Illinois’ seed-to-sale software likely presented a technical obstacle to those sales.

Four years later, I asked state officials whether that technical obstacle still exists. Despite multiple follow-up requests over the past several weeks, that question remains unanswered.

When they do, I’ll update this article.

Fun fact: One of the few long-form interviews ever given by Illinois’ Cannabis Regulation Oversight Officer was on my podcast.

Comment below with your thoughts and consider supporting my work!

#298 – Illinois Signs Major Cannabis Overhaul, Plus Q&A With Brad Spirrison – The Cole Memo

J.B. Pritzker, the Governor of Illinois, has officially signed Illinois' latest cannabis omnibus bill into law, marking one of the biggest updates to the state's cannabis regulations since adult-use legalization. In this episode, we livestream the signing ceremony from Sway Dispensary, break down the bill's major provisions, and hear directly from Governor J.B. Pritzker, social equity operators, patient advocates, physicians, and industry leaders about what the legislation is intended to accomplish. After the ceremony, journalist Brad Spirrison joins the show to discuss the cannabis questions he asked the governor, including what changes could still be made to Illinois' cannabis program and questions surrounding enforcement of the state's new hemp restrictions. We also answer viewer questions about medical cannabis access, implementation timelines, hemp beverages, home grow, and the future of cannabis policy in Illinois. Watch video version and read full show notes here: https://thecolememo.com/2026/07/02/e298/